1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome with Constipation Drugs Market
2.2. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2024 (US$ Million)
2.3. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2024 (US$ Million)
2.4. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Irritable Bowel Syndrome with Constipation Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Irritable Bowel Syndrome with Constipation Drugs Market Vendors
3.2. Strategies Adopted by Irritable Bowel Syndrome with Constipation Drugs Market Vendors

4. Irritable Bowel Syndrome with Constipation Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Irritable Bowel Syndrome with Constipation Drugs Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape

5. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Lubiprostone
5.3.2. Linaclotide
5.3.3. Stimulant Laxatives - Bisacodyl
5.3.4. Osmotic Laxatives
5.3.5. Lactulose
5.3.6. Polyethylene Glycol

6. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Prescribed
6.3.2. Over the Counter Type (OTC)


7. North America Irritable Bowel Syndrome with Constipation Drugs Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
7.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
7.4.Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)

8. UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)

9. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
9.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)

10. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
10.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
10.4.Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)

11. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
11.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
11.4.Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
11.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
11.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2023-2033, USD (Million)
11.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2023-2033, USD (Million)

12. Company Profile
12.1. Abbott Laboratories, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Ardelyx, Inc.
12.3. Astellas Pharma Inc.
12.4. AstraZeneca Plc.
12.5. Bayer AG
12.6. Fresenius Kabi AG
12.7. Ironwood Pharmaceuticals, Inc.
12.8. Sanofi S.A.
12.9. SK Biopharmaceuticals Co., Ltd.
12.10. Sucampo AG
12.11. Synergy Pharmaceuticals, Inc.
12.12. Synthetic Biologics, Inc.